City Holding CO Novartis Ag Transaction History

City Holding CO

$690 Million
Q3 2024

A detailed history of City Holding CO transactions in Novartis Ag stock. As of the latest transaction made, City Holding CO holds 135 shares of NVS stock, worth $13,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares

135

Previous 135 -0.0%

Holding current value

$13,105

Previous $14,000 7.14%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$92.57 - $107.37 $37,953 - $44,021	-410 Reduced 75.23%	135 $14,000
Q1 2024 Apr 11, 2024	SELL	$95.27 - $108.47 $1,714 - $1,952	-18 Reduced 3.2%	545 $52,000
Q3 2023 Oct 13, 2023	SELL	$94.73 - $105.13 $2,273 - $2,523	-24 Reduced 4.09%	563 $57,000
Q4 2022 Jan 27, 2023	SELL	$75.55 - $92.52 $9,972 - $12,212	-132 Reduced 18.36%	587 $0
Q1 2022 Apr 15, 2022	SELL	$80.11 - $90.62 $2,483 - $2,809	-31 Reduced 4.13%	719 $63,000
Q4 2021 Mar 11, 2022	SELL	$79.7 - $88.13 $35,227 - $38,953	-442 Reduced 37.08%	750 $66,000
Q2 2021 Jul 15, 2021	SELL	$85.24 - $94.15 $6,819 - $7,532	-80 Reduced 6.29%	1,192 $109,000
Q2 2020 Jul 13, 2020	SELL	$80.93 - $91.1 $1,133 - $1,275	-14 Reduced 1.09%	1,272 $111,000
Q1 2020 Apr 16, 2020	SELL	$70.67 - $99.01 $4,028 - $5,643	-57 Reduced 4.24%	1,286 $106,000
Q3 2019 Oct 15, 2019	BUY	$85.54 - $94.26 $6,073 - $6,692	71 Added 5.58%	1,343 $117,000
Q1 2018 Apr 12, 2018	BUY	$70.39 - $84.15 $2,041 - $2,440	29 Added 2.33%	1,272 $103,000
Q3 2017 Oct 17, 2017	BUY	$74.14 - $77.27 $92,156 - $96,046	1,243	1,243 $107,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of City Holding CO, based on Form 13F filings with the SEC.

News

Stay updated on City Holding CO with notifications on news.

Account